Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.
about
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fatCritical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice.Prolonged refeeding improves weight maintenance after weight loss with very-low-energy dietsThe Effects of Very-Low-Calorie Diets on HDL: A ReviewCombination of very low energy diets and pharmacotherapy in the treatment of obesity: meta-analysis of published data.Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.NPY receptors as potential targets for anti-obesity drug development.Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncologyCan neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.Modulation of neuropeptide Y receptors for the treatment of obesity.Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Very-low-energy diets and morbidity: a systematic review of longer-term evidence.Neuropeptide Y receptors: how to get subtype selectivityInvestigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.Emerging drugs for the treatment of obesity.Obesity Drug Update: The Lost Decade?Neural circuits of eating behaviour: Opportunities for therapeutic development.
P2860
Q21093205-98893991-8BB8-4ED6-9C83-128CB441DD0BQ33521218-11638EE6-258C-49AA-B839-D313B1892408Q34071242-A89600DB-5DA0-46A0-8480-252D9C3B250EQ34730842-222BA8EE-D799-4B78-B922-40D02833C90DQ35014095-36727210-6504-49DB-BFB2-4BBA3DC12C71Q35097218-70DA8CFD-521B-46FC-B07F-192122B280ABQ35130522-319A7B57-7A99-40D2-9A76-B141C8B05033Q36586203-63E00FD4-D0EE-4B1C-8D8F-03C5E99AC87BQ37337828-59616070-E0CF-41B7-9595-F1F3145EA6ABQ37589156-4075FBE2-247E-4F78-826D-FEF485723651Q37594773-69026F7A-EEA9-4D69-A681-456726A06652Q37779809-7B0CF59B-194C-413D-A124-48A41EF9F1DAQ38026643-5AE5220C-9EEF-4201-BB1C-EFACC4B08151Q38079230-D14A7E47-66E8-4064-B6D4-7BD90BA24EA5Q38226897-22E5A542-BD44-4C24-BB5F-3C8169CCE12CQ39031756-1E8F1831-CE51-4027-BDEA-A3067E8D5E9BQ46972562-7DCFDC81-B3E2-4C3A-B551-10951EECCF99Q50046451-4A7CCE90-9751-4778-8D8A-70CAF90CB74E
P2860
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@en
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@nl
type
label
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@en
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@nl
prefLabel
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@en
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@nl
P2093
P2860
P50
P356
P1433
P1476
Effect of NPY5R antagonist MK- ...... orie diet-induced weight loss.
@en
P2093
Allison Martin Nguyen
Arnaud Basdevant
Bret Musser
Harold Bays
John M Amatruda
Keith D Kaufman
Ngozi Erondu
Patrick M O'Neil
P2860
P304
P356
10.1038/OBY.2007.620
P577
2007-04-01T00:00:00Z